---
layout: cv
title: Samuel Whittle's CV
---
# Samuel Whittle
Rheumatologist & Epidemiologist

Rheumatology Unit, The Queen Elizabeth Hospital<br/>
28 Woodville Road, Woodville South<br/>
South Australia 5011<br/>

<a href="samuel.whittle@sa.gov.au">samuel.whittle@sa.gov.au</a> - +618 8222 6688  

<div id="webaddress">
  <a href="https://sam.xyz"><i class="fas fa-home"></i> sam.xyz</a> - 
  <a href="https://orcid.org/0000-0001-7417-7691"><i class="ai ai-orcid"></i> 0000-0001-7417-7691</a> - 
  <a href="https://twitter.com/samwhittle"><i class="fab fa-twitter"></i> @samwhittle</a>
</div>

## Qualifications

`1997`
**Bachelor of Medicine, Bachelor of Surgery (Honours)**, *University of Adelaide*  

`2004`
**Fellow of the Royal Australasian College of Physicians**   

`2010`
**Master of Clinical Epidemiology (with Distinction)**, *University of Newcastle*

## Experience

`2005-present`
**Staff Specialist in Rheumatology**, *The Queen Elizabeth Hospital*, Adelaide, South Australia.

`2013-present`
**Senior Lecturer**, *The University of Adelaide*, South Australia.

`2018-present`
**ANZMUSC Practitioner Fellow** 

`2018-present`
**Adjunct Senior Research Fellow**, *Monash University*, Melbourne, Australia.

`2009-2011`
Staff Specialist in Rheumatology, *The Lyell McEwin Hospital*, Adelaide, South Australia.

`2006-2008`
Director, Physician Training, *The Queen Elizabeth Hospital*, Adelaide, South Australia.

`2005-2009`
Rheumatology Private Practice, *Wakefield House*, Adelaide, South Australia.

`2005`
Research Student, *The University of Adelaide*, South Australia.

`2004`
Advanced Trainee in Rheumatology, *Repatriation General Hospital & Flinders Medical Centre*, Adelaide, South Australia.

`2003`
Specialist Registrar in Rheumatology, *St Peter's Hospital*, Chertsey, Surrey, UK.  

`2002`
Advanced Trainee in Rheumatology, *The Royal Adelaide Hospital & The Queen Elizabeth Hospital*, Adelaide, South Australia.  

`1998-2001`
Basic Physician Trainee, *The Royal Adelaide Hospital*, Adelaide, South Australia.  

`1997`
Intern, *The Royal Adelaide Hospital*, Adelaide, South Australia.  


## Professional Service  
`2019-2021`
**President, Australian Rheumatology Association South Australian Branch**  

`2019-2021`
**Board Member, Australian Rheumatology Association**    

`2014-present`
**Executive Committee Member, Australia & New Zealand Musculoskeletal Clinical Trials Network (ANZMUSC)**  

`2019-2024`
**Member, Cochrane Musculoskeletal Editorial Board**  

`2021-2024` 
**Steering Committee, South Australian Commission on Excellence and Innovation in Health Statewide Chronic Pain Clinical Network**   

`2021`
**Member, Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ) Vaccine-Induced Immune Thrombotic Syndrome Communications Committee**     

`2018`
**Steering Committee Member, National Strategic Action Plan for Arthritis**     

`2021`
**Member, Rheumatology Expert Writing Group, Rheumatology Guidelines 4th Edition**      

Other Australian Rheumatology Association Committees:  
  `2019-present`
    **Chair, Clinical Resources Committee**    
  `2016-2021`
    ASM Programme Committee  
  `2015-2018`
    Honorary Treasurer  
  `2014-2020`
    Financial Advisory Committee     
  `2016-2020`
    Sponsor Liaison Committee      
  `2008-2018`
    Representative to Asia-Pacific League of Associations for Rheumatology (APLAR)    
  `2015`
    Convenor, Annual Scientific Meeting, Adelaide     
  `2008-2012`
    Electronic Communications Committee      

`2008-present`
Associate Editor, International Journal of Rheumatic Diseases      

`2012-present`
Arthritis SA Education, Research & Advocacy Committee   


## Teaching  

`2008-present`
Co-ordinator, TQEH Med IV Rheumatology Teaching Programme  

`2012-2018`
RACP Educational Supervisor  

`2006-2008`
Director, Physician Training, Queen Elizabeth Hospital 


## Other Research Activity  

`2020`
Chair of Judging Panel, RACP South Australian Trainee Research Awards   

`2017-2018`
Fellow, OMERACT Shoulder Disorders Working Group   

`2019`
NZ Health Research Council Biomedical/Clinical Science Assessing Committee  

`2016`
Arthritis Research UK External Assessor  

`2011 & 2012`
NHMRC Grant Review Panel  

`2011, 2013, 2014`
NHMRC External Assessor   

`2014`
Dutch Organisation for Health Research and Development External Assessor    

## Research Supervision  

### PhD Students

`2018-present`
Dr Huai Leng (Jessica) Pisaniello. University of Adelaide.  
Co-supervisors: Professor Catherine Hill, Professor John Beltrame, Professor Will Dixon (Manchester)  

### Masters Students

`2017-2021`
Dr Chanakya Sharma. University of Western Australia.   
Co-supervisor: A/Prof Helen Keen (UWA)   

`2017-2020`
Judith Lowe. University of Adelaide.  
Co-supervisor: Prof Andrew Briggs (Curtin University)    


## Living Guidelines  

**An Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis**: [mskguidelines.org](https://app.magicapp.org/#/guideline/LqRV3n)      

  [Rheumatoid Arthritis: Dose Reduction or Discontinuation of bDMARDs and tsDMARDs](https://app.magicapp.org/#/guideline/LqRV3n/section/jOGV9j)  
  [Axial Spondyloarthritis: Dose Reduction or Discontinuation of bDMARDs](https://app.magicapp.org/#/guideline/LqRV3n/section/n3NGgL)  
  [Psoriatic Arthritis: Dose Reduction or Discontinuation of bDMARDs and tsDMARDS](https://app.magicapp.org/#/guideline/LqRV3n/section/j7gm0j)    
  [Opioids for Pain in Rheumatoid Arthritis](https://app.magicapp.org/#/guideline/LqRV3n/section/Lrp8OE)   
  [Opioids for Pain in Axial Spondyloarthritis](https://app.magicapp.org/#/guideline/LqRV3n/section/no78pn)   
  [Opioids for Pain in Psoriatic Arthritis](https://app.magicapp.org/#/guideline/LqRV3n/section/nJwamE)   
  [COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies](https://app.magicapp.org/#/guideline/LqRV3n/section/nY9yPn)      

## Publications  

*Publication list also available [in Google Scholar](https://scholar.google.com/citations?sortby=pubdate&hl=en&user=6P9otGEAAAAJ&view_op=list_works).*    

`2021`  
**Whittle SL**, Hazlewood GS, Robinson P, Johnston RV, Leder K, Glennon V, Avery JC, Grobler L, Buchbinder R. _COVID‐19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies (protocol)._ Cochrane Database of Systematic Reviews 2021, Issue 6. Art. No.: CD014991. DOI: 10.1002/14651858.CD014991

Sharma C, **Whittle S**, Haghighi P, Burstein F, Keen H. _Response to 'Correspondence on 'Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis'' by Reuter et al._ Ann Rheum Dis. 2021 Feb. doi.org/10.1136/annrheumdis-2020-219815  

Ferreira GE, Zadro JR, O’Keeffe M, Buchbinder R, Maher C, Latimer J, et al. _Challenges faced by musculoskeletal health research in Australia and New Zealand due to the COVID-19 pandemic._ Intern Med J. 2021;51: 622.  

Venter G, Tieu J, Black R, Lester S, Leonardo N, **Whittle SL**, et al. _Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis._ ACR Open Rheumatology. 2021; 3(4): 231-238. doi:10.1002/acr2.11234  

Adams L, Lester S, Hoon E, van der Haak H, Proudman C, Hall C, **Whittle S**, Proudman S, Hill C. _Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID-19 pandemic in Australia._ Internal Medicine Journal 2021. In press.   

`2020`  
Davis CR, Ruediger CD, Dyer KA, Lester S, Graf SW, Kroon FPB, **Whittle SL**, Hill CL. _Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH)._ Osteoarthritis Cartilage. 2020. doi:10.1016/j.joca.2020.11.002  

Buchbinder R, Ramiro S, Huang H, Gagnier JJ, Jia Y, **Whittle SL**. _Measures of adult shoulder function._ Arthritis Care Res (Hoboken). 2020 Oct;72 Suppl 10:250-293. doi: 10.1002/acr.24230  

Sharma C, **Whittle S**, Haghighi PD,Burstein F, Keen H. _Sentiment analysis of social media posts on pharmacotherapy: A scoping review._ Pharmacol Res Perspect. 2020;e00640. https://doi.org/10.1002/prp2.640  

Sharma C, **Whittle SL**, Delir Haghighi P, Burstein F, Sa’adon R, Keen H. _Mining Social Media Data to Investigate Patient Perceptions Regarding DMARD Pharmacotherapy for Rheumatoid Arthritis._ Ann Rheum Dis 2020. https://doi:10.1136/annrheumdis-2020-217333.  

Lowe J, Briggs AM, **Whittle S**, Stephenson MD. _A systematic review of the effects of probiotic administration in inflammatory arthritis._ Complement Ther Clin Pract. 2020; 101207.  

Leonardo N, Lester S, Graham M, Barrett C, **Whittle S**, Rowett D, et al. _Selection and perception of methotrexate treatment information in people with rheumatoid arthritis._ Int J Rheum Dis. 2020;15: 1586.  

Putman MS, Sufka P, **Whittle S**, Robinson PC. _European consensus statements for interstitial lung disease in systemic sclerosis_ [letter]. The Lancet Rheumatology. 2020;2: e317–e318.  

Hazlewood GS, **Whittle SL**, Kamso MM, Akl EA, Wells GA, Tugwell P, et al. _Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: a systematic review and network meta‐analysis._ Cochrane Database Syst Rev. 2020 [cited 8 Apr 2020]. doi:10.1002/14651858.CD013562  

Khadra Y, Walker JG, Hakendorf P, Proudman S, Rischmueller M, Hill CL, **Whittle S**, et al. _Scleroderma Renal Crisis: Observations from the South Australian Scleroderma Register._ Intern Med J. 2020. doi:10.1111/imj.14772  

Røe Y, Buchbinder R, Grotle M, **Whittle S**, Ramiro S, Huang H, et al. _What do the OMERACT Shoulder Core Set candidate instruments measure? An analysis using the refined ICF linking rules._ J Rheumatol. 2020. doi:10.3899/jrheum.190832   

Leonardo N, Lester S, **Whittle S**, Rischmueller M. _Review of gout clinic in a tertiary hospital setting._ Intern Med J. 2020;50: 117–120.  

Szeto C-C, Sugano K, Wang J-G, Fujimoto K, **Whittle S**, Modi GK, et al. _Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations._ Gut. 2020; gutjnl–2019–319300.  

`2019`   
Cai  K, **Whittle  SL**, Richards  BL, Ramiro  S, Falzon  L, Buchbinder  R. _Marine oil supplements for rheumatoid arthritis_. Cochrane Database of Systematic Reviews 2019, Issue 12. Art. No.: CD010250. DOI: 10.1002/14651858.CD010250.pub2.       

Ng J, Little CB, Woods S, **Whittle S**, Lee FY, Gronthos S, et al. _Stem Cell Directed Therapies for Osteoarthritis: the promise and the practice: Concise Review._ Stem Cells. 2019. doi:10.1002/stem.3139  

**Whittle SL**, Johnston RV, McDonald S, Paterson KL, Buchbinder R. _Autologous blood product injections including platelet-rich plasma for osteoarthritis of the knee. [protocol]._ Cochrane Database Syst Rev. 2019;24: 166.  

**Whittle SL**, Johnston RV, McDonald S, Worthley D, Mark Campbell T, Buchbinder R. _Stem cell injections for osteoarthritis of the knee. [protocol]._ Cochrane Database Syst Rev. John Wiley & Sons, Ltd; 2019; doi:10.1002/14651858.CD013342  

Chan FLY, Lester S, **Whittle SL**, Hill CL. _The utility of ESR, CRP and platelets in the diagnosis of GCA._ BMC Rheumatology. 2019;3: 14.  

Page MJ, O’Connor DA, Malek M, Haas R, Beaton D, Huang H, Ramiro S, Richards P, Voshaar  MJ, Shea B, Verhagen AP, **Whittle SL**, van der Windt DA, Gagnier JJ, Buchbinder R. _Patients’ experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set._ Rheumatology. 2019; doi:10.1093/rheumatology/kez046  

Tam LS, Wei JC-C, Aggarwal A, Baek HJ, Cheung PP, Chiowchanwisawakit P, Dans L, Gu J, Hagino N, Kishimoto M, Reyes HM, Soroosh S, Stebbings S, **Whittle SL**, Yeap SS, Lau CS. _2018 APLAR axial spondyloarthritis treatment recommendations._ Int J Rheum Dis. 2019; doi:10.1111/1756-185X.13510  

Ramiro S, Page MJ, **Whittle SL**, Huang H, Verhagen AP, Beaton D, et al. _The Omeract Core Domain Set for Clinical Trials of Shoulder Disorders._ J Rheumatol. 2019; doi:10.3899/jrheum.181070  

Wilsdon TD, **Whittle SL**, Thynne TR, Mangoni AA. _Methotrexate for psoriatic arthritis._ Cochrane Database Syst Rev. 2019;1: CD012722.   

`2018`  
Bourne AM, Johnston RV, Cyril S, Briggs AM, Clavisi O, Duque G, Harris IA, Hill C, Hiller C, Kamper SJ, Latimer J, Lawson A, Lin C-WC, Maher C, Perriman D, Richards BL, Smitham P, Taylor WJ, **Whittle S**, Buchbinder R. _Scoping review of priority setting of research topics for musculoskeletal conditions._ BMJ Open. 2018;8: e023962.   

Buchbinder R, Bourne A, Latimer J, Harris I, **Whittle S**, Richards B, et al. _Early development of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network._ Intern Med J. 2018; doi:10.1111/imj.14191  

Chua AC, Venkataraman K, **Whittle SL**. _Occipital condyle syndrome mimicking giant cell arteritis as the first manifestation of disseminated malignancy._ Internal Medicine Journal 2018; 48(9): 1163-4. http://dx.doi.org/10.1111/imj.14022  

Lowe J, Briggs A, **Whittle S**, Hoon E, Stephenson M. _Effectiveness of probiotics in the management of inflammatory arthritis: a systematic review protocol._ JBI Database System Rev Implement Rep. 2018; doi:10.11124/JBISRIR-2017-003692  

Pisaniello HL, Lester S, Gonzalez-Chica D, Stocks N, Longo M, Sharplin G, Dal Grande E, Gill T, **Whittle SL**, Hill C. _Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study._ Arthritis Res Ther (2018). Arthritis Res Ther. 2018 Jul 11;20(1):143. doi: 10.1186/s13075-018-1633-9.    

`2017`  
Black RJ, Lester S, Buchbinder R, Barrett C, Lassere M, March L, **Whittle S**, Hill CL. _Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry._ Arthritis Res Ther (2017); 19:253. DOI 10.1186/s13075-017-1461-3  

Wilsdon TD, **Whittle SL**, Thynne TRJ, Mangoni AA. _Methotrexate for psoriatic arthritis (Protocol)._ Cochrane Database of Systematic Reviews 2017, Issue 7. Art. No.: CD012722. DOI: 10.1002/14651858.CD012722.  

Goldacre, B., **Whittle, S**, Ernst, E. & Mendel, J. _Authors’ reply to Beales._ BMJ 356, j1196 (2017).  

Delir Haghighi P, Kang Y-B, Buchbinder R, Burstein F, **Whittle S**. _Investigating Subjective Experience and the Influence of Weather Among Individuals With Fibromyalgia: A Content Analysis of Twitter._ JMIR Public Health and Surveillance 3, e4 (2017).   

`2016`  
Truong SL, Saad NF, Robinson PC, Cowderoy G, Lim I, Schachna L, Stebbings S, Stuckey S, Taylor AL, **Whittle SL**, Zochling J, Bird P, Brown MA. _Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand._ J Med Imaging Radiat Oncol. 2016 Dec 19. doi:10.1111/1754-9485.12573.    

Mendel J, Goldacre B, Ernst E, **Whittle S**. Problems with ethical approval and how to fix them: lessons from three trials in rheumatoid arthritis. BMJ. 2016 Sep 9;i4626.  

Pisaniello HL & **Whittle SL**. _Fibromyalgia:  Finding the Silver Lining around a Common Chronic Pain Disorder._ Medicine Today 2016; 17(12): 54-56  

Milman N, Hill CL, **Whittle SL**, El Sayad J, Wells GA. _Methotrexate for giant cell arteritis (protocol)._ In: Cochrane Database of Systematic Reviews [Internet]. John Wiley & Sons, Ltd; 2016 [cited 2016 May 26]. Available from: [http://onlinelibrary.wiley.com.proxy.library.adelaide.edu.au/doi/10.1002/14651858.CD005323.pub3/abstract](http://onlinelibrary.wiley.com.proxy.library.adelaide.edu.au/doi/10.1002/14651858.CD005323.pub3/abstract)     

Milman N, **Whittle SL**, Hill CL, El Sayad J, Wells GA. _Methotrexate for polymyalgia rheumatica (protocol)._ In: Cochrane Database of Systematic Reviews [Internet]. John Wiley & Sons, Ltd; 2016 [cited 2016 May 26]. Available from: http://onlinelibrary.wiley.com.proxy.library.adelaide.edu.au/doi/10.1002/14651858.CD005325.pub3/abstract     

`2015`  
Ting KH, Hill CL, **Whittle SL**. _Quality of reporting of interventional animal studies in rheumatology: a systematic review using the ARRIVE guidelines._ Int J Rheum Dis. 2015 Jun;18(5):488-94. doi: 10.1111/1756-185X.12699.  

Graf SW, **Whittle SL**, Wechalekar MD, Moi JHY, Barrett C, Hill CL, Littlejohn G, Lynch N, Major G, Taylor AL, Buchbinder R, Zochling J. _Australian and New Zealand Recommendations for the Diagnosis and Management of Gout: integrating systematic literature review and expert opinion in the 3e initiative._ Int J Rheum Dis. 2015 Mar;18(3):341-51. doi: 10.1111/1756-185X.12557. Epub 2015 Apr 17.  

Ting K, Graf SW & **Whittle SL**. _Update on the diagnosis and management of gout._ Med J Aust 2015; 203 (2): 86-88.  

**Whittle S** & Buchbinder R. _In The Clinic: Rotator Cuff Disease._ Ann Intern Med. 2015 Jan 6;162(1):ITC1.    

`2014`  
Graf SW & **Whittle SL**. _Isotretinoin-induced skeletal hyperostosis._ Springerplus 2014 Nov 27;3(1):698.  

Moghaddami M, James M, **Whittle SL**, Cleland LG. _Synovial fluid myeloid dendritic cells display important differences compared to monocyte-derived dendritic cells prepared in vitro._ Clin Trans Immunol. 2014 Aug 8;3(8):e23.   

Richards BL, **Whittle SL**, Buchbinder R, Barrett C, Lynch N, Major G, et al. _Australian and New Zealand evidence-based recommendations for pain management by pharmacotherapy in adult patients with inflammatory arthritis._ International Journal of Rheumatic Diseases [Internet]. 2014 [cited 2014 Jun 3]; Available from: http://onlinelibrary.wiley.com/doi/10.1111/1756-185X.12388/full  

Robinson PC, Bird P, Lim I, Saad N, Schachna L, Taylor AL, **Whittle SL**, Brown MA. _Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA)._ International Journal of Rheumatic Diseases. 2014 (epub ahead of print; DOI 10.1111/1756-185X.12358)  

Bourne, A. M., **Whittle, SL**, Richards, B. L., Maher, C. G. & Buchbinder, R. _The scope, funding and publication of musculoskeletal clinical trials performed in Australia._ Med. J. Aust. 200(2): 88-91, (2014).    

`2013`  
**Whittle SL**, Colebatch AN, Adams K, Englbrecht M, Hazlewood G, et al. _Multinational Evidence-Based Recommendations for Pain Management by Pharmacotherapy in Inflammatory Arthritis: Integrating Systematic Literature Research and Expert Opinion of a Broad Panel of Rheumatologists in the 3e Initiative._ Rheumatology (March 24, 2012). Available from: http://rheumatology.oxfordjournals.org/content/early/2012/03/23/rheumatology.kes032.  

**Whittle SL**, Buchbinder R. _Opioid analgesics for rheumatoid arthritis pain._ JAMA 309, 485–486 (2013).  

Graf, SW, Buchbinder, R, Zochling, J & **Whittle, SL**. _The accuracy of methods for urate crystal detection in synovial fluid and the effect of sample handling: A systematic review._ Clin Rheumatol. 2013 Feb;32(2):225-32.  

`2012`  
**Whittle SL**, Richards, B. L., Ramiro, S. & Buchbinder, R. _Fish oil supplements for rheumatoid arthritis [protocol]._ In: Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd, 2012). at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010250/abstract   

**Whittle SL**, Richards, BL, van der Heijde, DM. & Buchbinder, R. _The efficacy and safety of opioids in inflammatory arthritis: a Cochrane systematic review._ J Rheumatol Suppl 90, 40–46 (2012).  

Richards, BL, **Whittle SL**, van der Heijde, DM & Buchbinder, R. _The efficacy and safety of neuromodulators in inflammatory arthritis: a Cochrane systematic review._ J Rheumatol Suppl 90, 28–33 (2012).  

Richards, BL, **Whittle SL**, van der Heijde, DM & Buchbinder, R. _The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review._ J Rheumatol Suppl 90, 21–27 (2012).  

Richards, BL,** Whittle SL**, van der Heijde, DM & Buchbinder, R. _The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review._ J Rheumatol Suppl 90, 34–39 (2012).  

Richards BL, **Whittle SL**, Buchbinder R. _Neuromodulators for pain management in rheumatoid arthritis._ Cochrane Database Syst Rev. 2012;1:CD008921.   

Richards BL, **Whittle SL**, Buchbinder R. _Muscle relaxants for pain management in rheumatoid arthritis._ Cochrane Database Syst Rev. 2012;1:CD008922.   

Wechalekar MD, Lester S, Proudman SM, Cleland LG, **Whittle SL**, Rischmueller M, et al. _Active foot synovitis: Criteria for remission and disease activity underestimate foot involvement in rheumatoid arthritis._ Arthritis & Rheumatism 2012; 64(5): 1316-1322   

`2011`  
**Whittle SL**, Richards BL, Husni E, Buchbinder R. _Opioid therapy for treating rheumatoid arthritis pain._ Cochrane Database Syst Rev. 2011;11:CD003113.   

Richards BL, **Whittle SL**, Buchbinder R. _Antidepressants for pain management in rheumatoid arthritis._ Cochrane Database Syst Rev. 2011;11:CD008920.     

`2010`  
Wechalekar MD, Rischmueller M, **Whittle S**, Burnet S, Hill CL. _Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab._ J Clin Rheumatol. 2010 Mar;16(2):79–80.   

Katikireddi VS, **Whittle SL**, Hill CL. _Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis._ Int J Rheum Dis. 2010 Feb 1;13(1):12–26.     

**Whittle SL**, Cole A, Lester S, Hill CL. _Steroid sparing drug treatments for polymyalgia rheumatica [Protocol]._ In: The Cochrane Collaboration, Hill CL, editors. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2009 [cited 2011 Apr 13]. Available from: http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD005325/abstract.html  

Hill CL, Cole A, Lester S, **Whittle SL**. _Steroid sparing drug treatments for giant cell arteritis [Protocol]._ In: The Cochrane Collaboration, Hill CL, editors. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2009 [cited 2011 Apr 13]. Available from: http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD005323/abstract.html    

`2008`  
Mangat P, **Whittle S**, Cleland L, Limaye V. _Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy._ Clin. Rheumatol. 2008 Dec;27(12):1593–5.      

`2004`  
**Whittle SL**, Hughes RA. _Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review._ Rheumatology (Oxford). 2004 Mar;43(3):267–71.  

**Whittle SL**, Hughes RA. _Methotrexate and folic acid: what is the optimal combination?_ (Letter). Rheumatology (Oxford). 2004 Aug; 43(8): 1061  

`2002`  
**Whittle SL**, James M, Cleland LG. _Focus on Meloxicam_ (Review). Medicine Today 2002; 3(9): 73-76     

`1996`  
Edwards DJ, **Whittle SL**, Nissen MJ, Cohen B, Oakeshott RD, Keene GC. _Radiographic changes in the knee after meniscal transplantation. An experimental study in a sheep model._ Am J Sports Med. 1996 Apr;24(2):222–6.


## Grants and funding

`2018-2021`
**ANZMUSC Practitioner Fellowship** ($398,520) 

`2018` 
**Arthritis Australia Project Grant**  (CIB): *Community perceptions of rheumatoid arthritis pharmacotherapy: an analysis of social media platforms* ($35,000)  

`2020-2021`
**Therapeutic Guidelines Ltd (TGL)/RACGP Foundation Research Grant** (TGL-03) (CI): *Use of Osteoarthritis Guidelines in General Practice: An Analysis of Work-as-Done Using the Functional Resonance Analysis Method*. ($19,968)   

`2019-2022`
**Australian Commonwealth Government Value in Prescribing Program: Biological Disease-Modifying Anti-Rheumatic Drugs** (GO1512) (Consortium Member) ($8,411,402)   

`2021-2024`
**MRFF Efficient Use of Existing Medicines** (APP2007502) (CII): *Cost-utility comparison of down-titration strategies for safer and more efficient use of biologics in adults with rheumatoid arthritis and psoriatic arthritis*, ($2.7M)


## Awards and Honours

`2017`
**Best Clinical Science Free Paper**, Australian Rheumatology Association Annual Scientific Meeting, Auckland, May 2017 (_The DAS28-P Index as a predictor of poor subjective response to DMARD therapy in early rheumatoid arthritis_) 

`2017`
**Tom Highton Award for Best Presentation** at the Annual Scientific Meeting of the New Zealand Rheumatology Association, Auckland, May 2017 (_The DAS28-P Index as a predictor of poor subjective response to DMARD therapy in early rheumatoid arthritis_)  

`2018`
**Best Poster**, OMERACT 2018, Terrigal NSW, May 2018 (*Instruments Measuring Pain in Shoulder Disorders*)  

`1997` 
**University Medal**, Health Sciences Division, The University of Adelaide  


## Invited talks

`2021`
Invited international speaker, New Zealand Rheumatology Association Annual Scientific Meeting, Dunedin NZ, August 2021  

_An Australian living guideline for the pharmacological management of inflammatory arthritis_, Cabrini Research Sessions, 12th May 2021  

_An Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis: Recommendations on Opioids for Pain in Inflammatory Arthritis_, Australian Rheumatology Association Webinar Series, 16th February 2021  

`2020`

_Development of the ANZMUSC Living Guidelines Conflict of Interest Process_, ANZMUSC Clinical Trials Network Mid-Year Scientific Meeting, 6 October 2020  

_An Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis: bDMARD Tapering Recommendations_, Australian Rheumatology Association Webinar Series, 16th November 2020  

_On Building a Living Evidence Ecosystem in Musculoskeletal Disease_, Australasian Society of Clinical Immunology and Allergy Educational Meeting, Adelaide, 15 December 2020  

`2019`  

_Talking Fibromyalgia_, Arthritis SA Community Seminar, 17 February 2019   

_Living Network Meta-analysis_, Cochrane Webinar, 21 March 2019  

_Biologics in Rheumatic Diseases 2019: Spoiled for Choice_, ASCEND Nurse Education Meeting, Adelaide, August 2019  

_On Building A Living Evidence Ecosystem in Musculoskeletal Disease_, RACP SA Annual Scientific Meeting, Adelaide, November 2019   

`2018`  

_ANZMUSC & Living Evidence: An Introduction_, ANZMUSC Update Meeting, Sydney, 28 November 2018  

`2017`  

_Fibromyalgia: A Rheumatological Construct?_, Arthritis SA Health Professionals Conference, 23 June 2017  

_Fibromyalgia_, Arthritis SA Community Seminar, 22 Oct 2017   

`2016`  

_Joint Pain in Osteoarthritis_, Global Year Against Pain in the Joints Public Forum, Australian Rheumatology Association Annual Scientific Meeting, Darwin, May 2016   

_Predictors of Response to Therapy in Psoriasis and Psoriatic Arthritis_, Novartis Rheumatology and Dermatology Preceptorship. Sydney, 17th September 2016  

_Ankylosing Spondylitis: TNF Inhibition and Beyond_, Novartis Rheumatology and Dermatology Preceptorship. Sydney, 18th September 2016  

_Chronic pain in rheumatology: fibromyalgia and beyond_, Faculty of Pain Medicine Regional CME meeting, Adelaide, 7th November 2016  





<br/>Last updated: 15 June 2021<br/><br/>
